Recombinant soluble receptors for the Fcγ portion inhibit antibody productionin vitro

Abstract
The problem of the structural relationship between suppressive IgG-binding factor and low-affinity receptors for the Fc portion of IgG (FcγRII) has not yet been solved. In the present work we have isolated a recombinant soluble FcγRII containing only the two external domains of FcγRII, and analyzed its biochemical characteristics and biological activity. A cDNA encoding FcγRII was mutated by the creation of a stop codon at the Lys175 codon. L cells have been transfected with this cDNA inserted into an expression vector. A cell line was obtained that secretes recombinant soluble FcγRII which reacts with a monoclonal anti-FcγRII antibody and binds to IgG1, IgG2a and IgG2b murine isotypes but not to IgG3 or F(ab')2 fragments of IgG2a. The secreted molecule contains two molecular species of relative molecular mass (Mr) 44 000 and 34 000–38 000 and of pI 4.5 and 6.3. They correspond to different glycosylations of a single polypeptide of Mr 19 000. After purification to homogeneity, soluble FcγRII has found to suppress secondary and primary in vitro antibody responses in a dose-dependent way. The present work shows that recombinant soluble FcγRII has biochemical characteristics, immunoreactivity and biological activity similar to those of suppressive IgG-binding factor.